Clinical Trial Update: GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety [NA]

View source ↗

Summary

The GRAVITAS trial evaluated whether adjusting clopidogrel therapy based on the VerifyNow P2Y12 assay affects thrombotic outcomes and safety in patients with ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Arteriosclerosis
• Coronary Syndrome

Drugs mentioned

• Plavix (clopidogrel)

Snippet

Sponsor: Accumetrics, Inc. | Conditions: Coronary Arteriosclerosis, Acute Coronary Syndrome | NA | Status: COMPLETED